Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Summary

The primary purpose of this single center, randomized, open label study in relapsing Multiple Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect of Preparation H (phenylephrine) Maximum Strength Cream compared to no topical treatment of injection site erythema after PLEGRIDY injection.

Timeline

Start

2015-07

Primary completion

2016-09

Completion

2016-09

Outcome

Outcome not reported

Stopped: “It was decided on 9/21/2016 to terminate this study early because LogPad devices the patients used to record their injection data was flawed”

Drugs

Indications